StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Johnson & Johnson
NYSE:JNJ
Sector
Location
Market Cap
USD 376.02 B
Share Price
USD 156.28
Avg Daily Volume
8,376,966
Change (1 day)
0.32%
Change (1 year)
6.28%
Change (YTD)
8.06%
Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2025: USD 24.78 B
Johnson & Johnson Operating Cash Flow is USD 24.78 B for the Trailing 12 Months (TTM) ending March 30, 2025, a 6.86% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 23.19 B, a 13.28% change year over year.
-
Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 20.47 B, a -12.19% change year over year.
-
Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending April 03, 2022 was USD 23.32 B, a -3.86% change year over year.
-
Johnson & Johnson Operating Cash Flow for the Trailing 12 Months (TTM) ending April 04, 2021 was USD 24.25 B, a 4.39% change year over year.
Competitors
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Haleon plc
USD 4.99
HLN.L
-0.05
-1.05%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.59
600436.SS
-0.10
-0.36%
Yunnan Baiyao Group Co.,Ltd
USD 7.80
000538.SZ
+0.00
0.06%
Nahdi Medical Company
USD 34.50
4164.SR
-0.16
-0.46%
Ajanta Pharma Limited
USD 30.68
AJANTPHARM.NS
+0.23
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 14.00
4527.T
+0.08
0.58%
Jamjoom Pharmaceuticals Factory Company
USD 44.94
4015.SR
+0.08
0.17%
Gerresheimer AG
USD 56.65
GXI.DE
-0.80
-1.39%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
-0.00
-0.09%
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Haleon plc
USD 4.99
HLN.L
-0.05
-1.05%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.59
600436.SS
-0.10
-0.36%
Yunnan Baiyao Group Co.,Ltd
USD 7.80
000538.SZ
+0.00
0.06%
Nahdi Medical Company
USD 34.50
4164.SR
-0.16
-0.46%
Ajanta Pharma Limited
USD 30.68
AJANTPHARM.NS
+0.23
0.77%
Rohto Pharmaceutical Co.,Ltd.
USD 14.00
4527.T
+0.08
0.58%
Jamjoom Pharmaceuticals Factory Company
USD 44.94
4015.SR
+0.08
0.17%
Gerresheimer AG
USD 56.65
GXI.DE
-0.80
-1.39%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
-0.00
-0.09%
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%